Thus, we have identified normal NKL homeobox gene activities in myelopoiesis and aberrantly expressed genes in AML and MDS patients, which include overexpressed NKL-code members and ectopically activated non-code members. The gene discussed is GLIS2; the disease is myelodysplastic syndrome.